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Introduction
Sepsis is associated with systemic, mediator-induced
alterations in oxygen utilization, including increased oxygen
demand, altered oxygen extraction, and decreased
myocardial contractility (Fig.1). Hence, despite a normal or
high cardiac output, severe sepsis and septic shock are
characterized by an inadequate organ oxygenation, leading
ultimately to multiple organ failure and death. Almost 20 years
ago, Abraham and colleagues [1] noted that survivors from
septic shock had significantly higher cardiac indexes prior to
the shock episode than did nonsurvivors, leading to the
suggestion that pushing patients to reach high and even
‘supranormal’ levels of cardiac output could be beneficial.
This early hypothesis has fueled an ongoing debate
regarding the potential benefit or harm of this strategy in the
patient with septic shock.
The ‘supranormal’ studies
Several groups have indicated increased survival in various
groups of patients treated with a strategy to increase cardiac
output or oxygen delivery (DO2) to so-called ‘supranormal’
values (cardiac index ≥4.5l/min per m2, DO2 <600ml/min
per m2 and oxygen consumption [VO2] >170ml/min per m2)
[2–9]. However, two notable studies conducted in mixed
groups of critically ill patients by Hayes and coworkers [10]
and Gattinoni and coworkers [11] showed that supranormal
DO2 values do not result in improved outcomes. A possible
explanation for those findings is that, unlike many of the other
studies in this field, the heterogeneity of the critically ill
patients included in the studies influenced the results. Thus,
although some individuals might well have benefited from the
trial strategy, these positive results may have been negated
by harmful effects in other patients who perhaps had already
been adequately resuscitated and therefore received
excessive doses of vasopressor agents or fluids. There is
little doubt that, in certain patients, achieving and maintaining
high levels of cardiac output is associated with improved
outcomes; the difficulty lies in identifying those patients.
Should we maintain adequate cardiac output
in all patients with septic shock?
The available studies suggest that rather than protocolize all
patients to increased cardiac output and DO2, this strategy
should be tailored to the individual patient. Hayes and
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Abstract
Despite a usually normal or high cardiac output, severe sepsis is associated with inadequate tissue
oxygenation, leading to organ failure and death. Some authors have suggested that raising cardiac
output and oxygen delivery to predetermined supranormal values may be associated with improved
survival. While this may be of benefit in certain patients, bringing all patients to similar, supranormal
values, is simplistic. It is much preferable to titrate therapy according to the needs of each individual
patient. A combination of variables should be used for this purpose, in addition to a careful clinical
evaluation, including not only cardiac output but also the mixed venous oxygen saturation and the
blood lactate concentrations. The concept is to assess the adequacy of the cardiac output in patients
with severe sepsis, enabling management strategies aimed at optimizing cardiac output to be tailored
to the individual patient.
Keywords mixed venous oxygen, oxygen delivery, oxygen uptake, saturation277
Available online http://ccforum.com/content/7/4/276
coworkers [6] suggested that survivors from septic shock are
characterized by an ability to increase DO2 and VO2, whereas
nonsurvivors do not have sufficient physiologic reserve to do
this, and in such patients excessive doses of vasopressors or
fluids worsen an already bad situation. Rather than making
attempts to target cardiac output and DO2 randomly in all
patients, our approach should rather be to try to restore
hemodynamic stability, which will necessitate different
approaches in different patients. Indeed, no one would
dispute the need for clinical interventions to enhance DO2
and support the circulation where tissue perfusion is clearly
inadequate. The problem lies in identifying those patients in
whom tissue hypoxia is less overt, who may in fact have
‘normal’ hemodynamic parameters, and augmenting DO2 in
such patients may necessitate reaching ‘supranormal’ values.
So, how can we determine which patients require what
therapy? Perhaps the mixed venous oxygen saturation (SvO2)
is the most important parameter to follow. SvO2 provides an
indication of the degree of oxygen extracted by the organs
before the blood returns to the right heart and hence gives a
measure of the balance between DO2 and VO2, thus
providing an indication of the ability of the cardiac output to
meet the individual’s oxygenation needs. Admittedly, SvO2 is
a global parameter and gives no specific regional information,
but neither does cardiac output; in fact, it may be interesting
to combine SvO2 and cardiac output (Fig.2). Indeed, this is
one of the problems with the less invasive methods of
measuring cardiac output; we are all agreed that ‘less
invasive’ is the way to go, but how does one interpret cardiac
output values without knowledge of the SvO2? Some may say
that SvO2 monitoring is useless in sepsis or septic shock
because, in sepsis, SvO2 may be normal or high despite
regional tissue hypoxia, because of altered tissue oxygen
extraction. However, clinical evidence shows that SvO2 does
fluctuate in patients with sepsis or septic shock [12], and
there are two major arguments in support of the value of
SvO2 monitoring in sepsis. First, Ronco and coworkers [13]
noted that patients who are about to die may still have high
oxygen extraction capabilities. Hence, in septic shock, a high
or normal SvO2 does not necessarily mean that oxygen
extraction cannot increase further. Second, Rivers and
coworkers [14] showed, in a patient population treated in an
emergency department, that the initial central venous oxygen
saturation (measured as a substitute for SvO2) was only
48.6±11.2%. Hence, it is only after initial resuscitation that
central venous oxygen saturation (or SvO2) may reach normal
(or supranormal) values. Conversely, it may decrease again if
there is hypovolemia or myocardial depression.
Importantly, it is not necessary to calculate DO2. Moreover,
the relationship between VO2 and DO2 is subject to
mathematical coupling of data. In complex cases, the relation
between cardiac index and oxygen extraction ratio may be
helpful, especially in anemia [15,16]. Finally, blood lactate
levels may help to identify the patient who requires a higher
cardiac output because survivors from septic shock have
significantly lower initial blood lactate levels and their blood
lactate levels are raised for shorter periods of time [17].
Another important feature may be the timing of optimization.
In the early studies conducted by Shoemaker and
coworkers [2] that showed improved outcome in surgical
patients, optimization was commenced before the surgical
procedure. Rivers and coworkers [14] recently showed the
beneficial effects of early goal-directed therapy, within
6 hours of diagnosis of septic shock, over standard therapy.
The methods for increasing cardiac output or DO2 (e.g.
fluids, inotropes, and blood transfusions) may also impact
on results.
Figure 1
Influence of sepsis mediators on the relationship between oxygen
uptake and delivery.
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Figure 2
Interpretation of cardiac output according to mixed venous oxygen
saturation (SvO2) values. VO2, oxygen consumption.
CARDIAC OUTPUT
HIGH                             LOW
SvO2                       SvO2
HIGH              LOW         HIGH LOW
SEPSIS
EXCESSIVE
BLOOD FLOW
(hypervolemia,
excessive vasoactive
therapy)
ANEMIA
HYPOXIA
HIGH VO2
inadequate
cardiac output?
LOW VO2
(anesthesia,
hypothermia, ...)
adequate
cardiac output?
LOW OUTPUT
SYNDROME
(hypervolemia,
heart failure
pulmonary embolism ...)278
Critical Care    August 2003 Vol 7 No 4 Vincent
Conclusion
More important than achieving supranormal DO2 and, hence,
oxygen consumption in those patients who may benefit from
this strategy is achieving optimal hemodynamic status in all
patients (Fig.3). If augmentation of DO2 is associated with a
reduction in serum lactate levels and improved target organ
perfusion, then these interventions may be continued. Each
patient must be assessed according to their clinical (urine
output, skin perfusion, mental status), hemodynamic (arterial
pressure, cardiac output), and oxygenation (SvO2, blood
lactate) parameters. Practising good medicine is never
simple, and applying protocols to reach supranormal DO2 in
all patients is naïve. The challenge is to identify which
approach is needed in which patient so that all patients
receive optimal care.
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Figure 3
Schematic showing the combination of variables involved in the
assessment of the patient with septic shock.
Is the patient on vasopressor agents ?
yes             no
primary goal =
    wean from vasopressors
fluid challenge ?
dobutamine
primary goal =
   adequate tissue perfusion
no            yes
do nothing !
(transfusions ?)
adequate tissue perfusion ?
(skin, mental status, blood lactate levels...)